Navigation Links
Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
Date:8/13/2007

PHILADELPHIA − Concentrated chemicals derived from green tea dramatically boosted production of a group of key detoxification enzymes in people with low levels of these beneficial proteins, according to researchers at Arizona Cancer Center.

These findings, published in the August issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, suggest that a green tea concentrate might help some people strengthen their metabolic defense against toxins capable of causing cancer.

In a study of 42 people, the concentrate − composed of chemicals known as green tea catechins in amounts equal to that found in 8-16 cups of green tea − boosted production of the enzymes, which belong to the glutathione S-transferase (GST) family, by as much as 80 percent in some participants.

GST enzymes are believed to be crucial to the bodys defense against cancer-causing chemicals and other toxins, according to the studys lead investigator, H.-H. Sherry Chow, Ph.D., a research associate professor at the University of Arizona. They modify the cancer-causing molecules that would otherwise damage cellular DNA, thus rendering them inert.

They actually convert known carcinogens to non-toxic chemicals, and studies have shown a correlation between deficient expression of these enzymes and increased risk of developing some cancers, Chow said.

Expression of this enzyme varies dramatically in people due to genetic variation and environmental factors, Chow added. Green tea catechins somehow increase gene expression of these enzymes, which can be an advantage to people with low levels to start with.

Green tea has long been of interest to researchers given studies that have shown populations in which it is often consumed, such as the Chinese and Japanese, generally have lower rates of cancer. To find out if green tea can protect against cancer, the NCI has sponsored a numbe
'/>"/>

Contact: Greg Lester
lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

2

GOOD

Page: 1 2

Related biology news :

1. New research indicates a troubled greenhouse is brewing
2. Genetic defects give the immune system the green light to attack the pancreas
3. While on trail of dioxin, scientists pinpoint cancer target of green tea
4. UN successfully tests green pesticide against locusts
5. Green catalyst destroys pesticides and munitions toxins, finds Carnegie Mellon University
6. Bacteria are key to green plastics, drugs
7. New tools used to control foodborne hepatitis A outbreaks related to green onions
8. Green diesel: New process makes liquid transportation fuel from plants
9. FDA: Highly Unlikely Green Tea Lowers Cancer Risk
10. Microbes under Greenland Ice may be preview of what scientists find under Mars surface
11. Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2012)... Hospitals (UH) Case Medical Center and CardioKinetix Inc., ... for heart failure, today announced promising results for ... Percutaneous Ventricular Restoration Therapy (PVRT) technology for patients ... two-year clinical results were presented today (May 18, ... Late Breaking Science Hot Line session at the ...
(Date:5/17/2012)... participate in genetic testing that can indicate their ... these results does not appreciably drive up or ... health services, according to a study performed by ... colleagues at other institutions. , The study in ... Genetics in Medicine was done by ...
(Date:5/17/2012)... have shown that zebrafish could be used to ... The study, published online in the journal ... their behaviour in response to varying situations. , ... Biological and Chemical Sciences who led the study, ... useful animal models for studying the developmental genetic ...
Breaking Biology News(10 mins):UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure 2UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure 3NIH-led study finds genetic test results do not trigger increased use of health services 2NIH-led study finds genetic test results do not trigger increased use of health services 3NIH-led study finds genetic test results do not trigger increased use of health services 4Zebrafish could hold the key to understanding psychiatric disorders 2GEN point of view article questions reported costs of drug R 26amp 3BD 20192 1GEN point of view article questions reported costs of drug R 26amp 3BD 20192 2Microalgae could be Texas next big cash crop 20189 1Microalgae could be Texas next big cash crop 20189 2Microalgae could be Texas next big cash crop 20189 3Binge Eating May Be a High All Its Own 83454 1Binge Eating May Be a High All Its Own 83454 2Binge Eating May Be a High All Its Own 83454 3
... the Biomedical Engineering Society (BMES) will launch a ... (CMBE) in March 2008. Springer is already ... Biomedical Engineering. , Cellular and Molecular Bioengineering ... of cellular and molecular bioengineering, thus advancing this ...
... between Plant Physiology and The Arabidopsis Information Resource (TAIR) ... genetic and molecular data on Arabidopsis published in the ... collaborationthe first of its kind-- provides authors with the ... and gene information to the TAIR database at the ...
... significant role in retaining human-generated nitrogen, serving as the ... up in estuaries and oceans, finds a paper published ... Hampshire professor William McDowell and research scientist Jody Potter, ... the co-authors of the study, led by Patrick Mulholland ...
Other Biology News:Springer expands publishing partnership with the Biomedical Engineering Society 2Plant Physiology and TAIR partnership will provide genetic information to public database 2Plant Physiology and TAIR partnership will provide genetic information to public database 3Streams remove significant amounts of nitrogen, preventing downstream 'dead zones' 2
(Date:5/16/2012)... May 16, 2012  Questcor Pharmaceuticals, Inc. (NASDAQ: ... Board of Directors has increased the Company,s common ... million shares. Since the beginning of ... shareholders through the repurchase of approximately 19.2 million ... its shares as of the commencement of the ...
(Date:5/15/2012)... Researchers have taken a step toward overcoming ... structures that could bring optical advances including ... The researchers have shown how to create ... gold previously required, said Alexandra Boltasseva, a ... computer engineering. , Using the metals is ...
(Date:5/15/2012)... -- Cardium Therapeutics (NYSE Amex: CXM ... first quarter ended March 31, 2012, and other ... In addition to the announcement ... its goals for 2012, which were outlined in ... advance commercialization of its new Excellagen® advanced, physician-use ...
(Date:5/14/2012)... connection, if any, between sudden cardiac death and people ... lives? , In a comprehensive, 10-year UCSF study, researchers ... a rate four times higher than the general population. ... we were looking at every instance of sudden death ... MD, an electrophysiologist and an associate professor of medicine ...
Breaking Biology Technology:Questcor Pharmaceuticals Expands Repurchase Program 2Questcor Pharmaceuticals Expands Repurchase Program 3Questcor Pharmaceuticals Expands Repurchase Program 4Questcor Pharmaceuticals Expands Repurchase Program 5New 'metamaterial' practical for optical advances 2New 'metamaterial' practical for optical advances 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 2Cardium Presents First Quarter 2012 Financial Results and Recent Developments 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 4Cardium Presents First Quarter 2012 Financial Results and Recent Developments 5Cardium Presents First Quarter 2012 Financial Results and Recent Developments 6Cardium Presents First Quarter 2012 Financial Results and Recent Developments 7Cardium Presents First Quarter 2012 Financial Results and Recent Developments 8Cardium Presents First Quarter 2012 Financial Results and Recent Developments 9Cardium Presents First Quarter 2012 Financial Results and Recent Developments 10Cardium Presents First Quarter 2012 Financial Results and Recent Developments 11Are people with HIV/AIDS more prone to sudden cardiac death? 2Are people with HIV/AIDS more prone to sudden cardiac death? 3
... HALIFAX, May 28 /PRNewswire-FirstCall/ - MedMira Inc., ("MedMira") (TSX ... and marketer of rapid diagnostic technology and solutions, announced ... Company,s U.S. distribution network. Headquartered in West Chester, Pennsylvania, ... with worldwide sales in excess of $3.7 billion. , ...
... The Food and Drug Administration (FDA) has granted ... Prograf(R) (tacrolimus) in conjunction with mycophenolate mofetil (MMF) for ... Prograf is a cornerstone therapy for preventing transplant ... approval came on May 19, 2009 in response to ...
... of Global Distribution Agreements to Make ZyGEM,s Lower-Cost, ... Researchers Everywhere--ZyGEM Also Announces Issuance of U.S. Patent ... Calif. and HAMILTON, New Zealand and ANN ... today announced that it has entered into an ...
Other Biology Technology:MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States 2Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 2Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 3Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 4Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 5Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 6ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicon's Research and Diagnostic Products 2ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicon's Research and Diagnostic Products 3ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicon's Research and Diagnostic Products 4
... system designed for flexibility and routine operation. ... ion lens, true hyperbolic quadrupole and high-speed ... widest range of sample types and applications. ... as standard Agilents unique ShieldTorch System, which ...
... except that it uses a deep-UV deuterium bulb, ... comes with a shutter (controlled via a TTL ... The DH-2000 Deuterium Tungsten Halogen Light Source ... halogen light sources in a single optical path. ...
... OPTIMA is a fully automated microplate ... the widest possible range of applications ... gene assays luciferase, -galactosidase, gene activities ... dioxetanes..) Luminescent Immunoassays Cell-based ...
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells...
Biology Products: